文献速递主动脉疾病颈动脉与弓上血管

腔内时代的颈部去分支化:单中心经验

Cervical Debranching in the Endovascular Era: A Single Centre Experience.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2019-06-14

该回顾性单中心研究纳入2010至2017年间201例接受211次颈部去分支化手术的患者,作为 hybrid 主动脉弓修复的一部分。结果显示30天死亡率为7.6%,主要卒中发生率为4.3%,局部出血并发症占11.4%。一期 hybrid 手术较分期或单纯去分支化显著增加30天死亡率(15% vs 4.9%,p=.018)。

要点

  • 颈部去分支化通畅率优秀(一期累积通畅率98.1%),但局部并发症发生率显著。
  • 一期 hybrid 手术(同期 TEVAR 加去分支化)较分期或单纯去分支化30天死亡率更高(15% vs 4.9%,p=.018)。
  • 颈动脉-锁骨下动脉旁路术较其他术式术后并发症显著更少,可能更安全。

核心结论

  • 颈部去分支化手术通畅率优秀,但局部并发症发生率显著。
  • 颈动脉-锁骨下动脉旁路术并发症显著更少,可能更安全。
  • 分期 hybrid 手术似乎更安全,一期 hybrid 手术30天死亡率更高。

研究设计与样本

  • 回顾性单中心研究,纳入2010至2017年间所有连续接受颈部去分支化手术作为 hybrid 主动脉弓修复一部分的患者。
  • 共201例患者,接受211次颈部去分支化手术。
  • 平均年龄67.7±10.7岁,男性占70.6%(142/201),平均 BMI 26.3±5。

主要发现

  • 30天死亡率为7.6%(16/211);单纯去分支化无 TEVAR 时死亡1例(0.5%)。
  • 主要卒中发生率为4.3%(9/211);单纯去分支化后无卒中发生。
  • 局部周围神经损伤19例(9.5%),乳糜瘘8例(3.8%),局部伤口感染5例(2.4%),旁路移植物感染1例(0.5%)。
  • 随访平均15±17个月(范围0-89个月),一期累积移植物通畅率98.1%(207/211),二期通畅率100%。

关键数值与推荐

  • 一期 hybrid 手术(同期 TEVAR 加颈部去分支化)30天死亡率为15%(9/60),单纯去分支化或分期 hybrid 手术为4.9%(7/144),p=.018。
  • 卒中与较长手术时间相关(OR 1.006;95%CI 1.000-1.011;p=.045)。
  • 卒中与较高 BMI 相关(OR 1.195;95%CI 1.009-1.415;p=.039)。
  • 手术方式分布:颈动脉-锁骨下动脉旁路术单独166/211(78.7%),锁骨下动脉转位至同侧颈动脉17/211(8.1%),联合术式28例(13.3%)。

临床怎么用

  • 颈部去分支化可作为 hybrid 主动脉弓修复的可行选择,通畅率优秀。
  • 优先考虑颈动脉-锁骨下动脉旁路术,因其术后并发症显著更少。
  • 对适合的患者,优先选择分期 hybrid 手术而非一期同期手术,以降低30天死亡率。
  • 关注局部并发症(出血、神经损伤、乳糜瘘、感染),尤其需再干预的情况。

局限性

  • 回顾性单中心研究设计。
  • 随访时间平均仅15±17个月,范围0-89个月,中远期结果有限。
  • 样本来自单一三级中心,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE/BACKGROUND: Debranching of the supra-aortic arteries is a common practice either as part of a hybrid treatment of aortic arch pathology or owing to arterial occlusive disease. Results of the debranching techniques have not been reported frequently. METHODS: This was a retrospective single centre study of all consecutive patients with cervical debranching procedures as part of hybrid aortic arch repair. RESULTS: Between 2010 and 2017, 201 patients underwent 211 cervical debranching procedures in a tertiary centre. Mean ± SD patient age was 67.7 ± 10.7 years (70.6% males; n = 142/201) and mean ± SD body mass index (BMI) was 26.3 ± 5. In 78.7% of the cases carotid-subclavian bypass was performed alone (n = 166/211) followed by transposition of the subclavian artery to the ipsilateral carotid (n = 17/211; 8.1%) and in 28 cases (13.3%) a combination of procedures was performed. Twenty-four cases (11.4%) were complicated with local bleeding and 21 cases required re-intervention (10.4%). Nineteen patients (9.5%) developed local peripheral neurological damage post-operatively. Eight patients (3.8%) developed a chylous fistula and five (2.4%) presented with a local wound infection. One patient (0.5%) developed a bypass graft infection. The thirty day mortality was 7.6% (n = 16/211): one death occurred after isolated debranching without thoracic endovascular aneurysm repair (TEVAR; 0.5%). Whether the hybrid procedures were undertaken in a single stage (simultaneous TEVAR and cervical debranching) or two stage fashion appeared to have a significant impact on 30 day mortality (single stage n = 9/60 [15%] vs. debranching alone or two stage hybrid procedures n = 7/144 [4.9%]; p = .018). The major stroke incidence was 4.3% (n = 9/211); no strokes occurred after isolated debranching. Stroke was correlated with longer operating times (odds ratio [OR] 1.006; 95% confidence interval [CI] 1.000-1.011; p = .045) and higher BMI (OR 1.195; 95% CI 1.009-1.415; p = .039). Mean ± SD follow up was 15 ± 17 months (range 0-89 months). Primary cumulative graft patency during follow up was 98.1% (n = 207/211) and secondary patency was 100%. CONCLUSION: The results of cervical debranching procedures showed not only excellent patency rates, but also a significant rate of local complications. Carotid-subclavian bypass appeared to be safer with significantly fewer post-operative complications. Staged hybrid procedures also seemed to be safer.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Konstantinou N, Debus ES, Vermeulen CFW, et al. Cervical Debranching in the Endovascular Era: A Single Centre Experience. Eur J Vasc Endovasc Surg. 2019. PMID: 31204185. doi:10.1016/j.ejvs.2018.12.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。